These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 18838297)
1. Nonimmune cells in inflammatory bowel disease: from victim to villain. Danese S Trends Immunol; 2008 Nov; 29(11):555-64. PubMed ID: 18838297 [TBL] [Abstract][Full Text] [Related]
2. Immune and nonimmune components orchestrate the pathogenesis of inflammatory bowel disease. Danese S Am J Physiol Gastrointest Liver Physiol; 2011 May; 300(5):G716-22. PubMed ID: 21233277 [TBL] [Abstract][Full Text] [Related]
3. Immunology of inflammatory bowel diseases. Lakatos L Acta Physiol Hung; 2000; 87(4):355-72. PubMed ID: 11732889 [TBL] [Abstract][Full Text] [Related]
4. Inflammation and the mucosal microcirculation in inflammatory bowel disease: the ebb and flow. Danese S Curr Opin Gastroenterol; 2007 Jul; 23(4):384-9. PubMed ID: 17545773 [TBL] [Abstract][Full Text] [Related]
5. Inflammation and coagulation in inflammatory bowel disease: The clot thickens. Danese S; Papa A; Saibeni S; Repici A; Malesci A; Vecchi M Am J Gastroenterol; 2007 Jan; 102(1):174-86. PubMed ID: 17100967 [TBL] [Abstract][Full Text] [Related]
7. How intestinal epithelial cells tolerise dendritic cells and its relevance to inflammatory bowel disease. Shale M; Ghosh S Gut; 2009 Sep; 58(9):1291-9. PubMed ID: 19671557 [TBL] [Abstract][Full Text] [Related]
8. Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease. Kanai T; Nemoto Y; Kamada N; Totsuka T; Hisamatsu T; Watanabe M; Hibi T Curr Opin Gastroenterol; 2009 Jul; 25(4):306-13. PubMed ID: 19448533 [TBL] [Abstract][Full Text] [Related]
9. Neuro-glial crosstalk in inflammatory bowel disease. Neunlist M; Van Landeghem L; Bourreille A; Savidge T J Intern Med; 2008 Jun; 263(6):577-83. PubMed ID: 18479256 [TBL] [Abstract][Full Text] [Related]
10. Role of the vascular and lymphatic endothelium in the pathogenesis of inflammatory bowel disease: 'brothers in arms'. Danese S Gut; 2011 Jul; 60(7):998-1008. PubMed ID: 21212253 [TBL] [Abstract][Full Text] [Related]
12. Innate and adaptive immune connections in inflammatory bowel diseases. Rakoff-Nahoum S; Bousvaros A Curr Opin Gastroenterol; 2010 Nov; 26(6):572-7. PubMed ID: 20871398 [TBL] [Abstract][Full Text] [Related]
13. Role of the innate immune system in the pathogenesis of inflammatory bowel disease. van Lierop PP; Samsom JN; Escher JC; Nieuwenhuis EE J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):142-51. PubMed ID: 19179875 [TBL] [Abstract][Full Text] [Related]
17. Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gonzalez-Rey E; Anderson P; González MA; Rico L; Büscher D; Delgado M Gut; 2009 Jul; 58(7):929-39. PubMed ID: 19136511 [TBL] [Abstract][Full Text] [Related]
18. Susceptibility genes and overall pathogenesis of inflammatory bowel disease: where do we stand? Fiocchi C Dig Dis; 2009; 27(3):226-35. PubMed ID: 19786745 [TBL] [Abstract][Full Text] [Related]
19. Environmental factors affecting inflammatory bowel disease: have we made progress? Lakatos PL Dig Dis; 2009; 27(3):215-25. PubMed ID: 19786744 [TBL] [Abstract][Full Text] [Related]
20. Translating inflammatory bowel disease research into clinical medicine. Neurath MF; Finotto S Immunity; 2009 Sep; 31(3):357-61. PubMed ID: 19766078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]